Advanced Search

 

Study ID Status Title Patient Level Data
113783 Completed A Fixed-Dose Study of Lamotrigine versus Placebo in the Long Term Prevention of Relapse and/or Recurrence of a Manic, Hypomanic, Mixed or Depressive Episode in Adult Subjects with Bipolar I Disorder
113784 Completed 31P MRS Ischaemic Exercise Optimisation and COPD Myopathy Study
113789 Completed A Randomized, Placebo-Controlled, Double-Blind, Four-way Crossover Study to Assess the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, with Moxifloxacin as a Positive Control in Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
113794 Terminated A Phase I Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects with Advanced Solid Tumors.
113797 Completed An open label, multi-centre, non-interventional post-marketing surveillance to monitor the safety and effectiveness of AVODART® administered in Korean androgenetic alopecia patients according to the prescribing information
113806 Completed An open-label, single-arm, Phase I/II study of lapatinib in combination with weekly paclitaxel as first-line chemotherapy for ErbB2-overexpressing Metastatic Breast Cancer patients
113807 Completed Phase IIIb immunogenicity, safety and reactogenicity study of GSK Biologicals’ meningococcal vaccine [GSK 134612] when given as one dose to healthy subjects aged 56 years or older Study Listed on ClinicalStudyDataRequest.com
113808 Completed Efficacy, immunogenicity and safety of two doses of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Liquid Human Rotavirus (HRV) Vaccine (444563), in healthy infants Study Listed on ClinicalStudyDataRequest.com
113809 Completed Immunological non-inferiority between two process-manufactured influenza vaccines in adults aged 18 to 60 years Study Listed on ClinicalStudyDataRequest.com
113810 Terminated Safety and immunogenicity study of GSK Biologicals’ pandemic influenza candidate vaccine (GSK2340272A) in children aged 3 to 9 years Study Listed on ClinicalStudyDataRequest.com
113817 Completed Characterisation of healthy volunteers, asthma and Chronic Obstructive Pulmonary Disease patients for inhalation profile, pharyngometry, spirometric indices and lung morphometry
113818 Completed A Phase I, single-center, drug interaction study between simvastatin, atorvastatin, rosuvastatin, and GSK2248761 in healthy subjects.
113819 Completed Safety and Immunogenicity of GSK Biologicals’ Herpes Zoster vaccine 1437173A in healthy ethnic Japanese adults
113822 Active, Not Recruiting Risk score for venous thromboembolism
113823 Completed Immunogenicity and safety study of GSK Biologicals’ meningococcal vaccine 134612 with or without co-administration of Cervarix and Boostrix in female adolescents and young adults at 9-25 years of age
113839 Completed Angiogenesis Inhibitor Therapies for Advanced Renal Cell Carcinoma: Toxicity and Treatment Patterns in Clinical Practice from a Global Medical Chart Review Study
113847 Completed Safety and immunogenicity study of GSK Biologicals’ pandemic influenza (H1N1) candidate vaccine (GSK2340274A) in Japanese children aged 6 months to 17 years Study Listed on ClinicalStudyDataRequest.com
113854 Completed A study in adult subjects with chronic hepatitis B infection to support the development of immunological assays
113865 Completed Fluticasone propionate-salmeterol combination adherence in Patients with Chronic Obstructive Pulmonary Disease (COPD)
113866 Completed Safety and immunogenicity study of GSK Biologicals’ influenza vaccine GSK2340272A in adults aged 18 to 60 years Study Listed on ClinicalStudyDataRequest.com
113872 Completed A Randomized, Double-Blind, Parallel Group study of ADVAIR™ DISKUS™ 100/50 and FLOVENT™DISKUS™ 100, both twice daily, in a Pediatric Population during the Fall Viral Season. Study Listed on ClinicalStudyDataRequest.com
113874 Completed A Randomized, Double-Blind, Parallel Group, Multicenter Study of the Effects of Fluticasone Propionate/Salmeterol Combination Product 250/50mcg BID (ADVAIR DISKUS™) in Comparison to Salmeterol 50mcg BID (SEREVENT DISKUS™) on the Rate of Exacerbations of COPD Following Hospitalization Study Listed on ClinicalStudyDataRequest.com
113877 Completed A study of fluticasone propionate/salmeterol DISKUS combination product 250/50 mcg twice daily plus tiotropium 18 mcg daily versus placebo DISKUS twice daily plus tiotropium 18 mcg daily on exercise time and physiological parameters in subjects with Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
113883 Completed Safety and immunogenicity study of GSK Biologicals’ pandemic influenza (H1N1) candidate vaccine (GSK2340274A) in children aged 10 to less than 18 years Study Listed on ClinicalStudyDataRequest.com
113886 Completed A Phase I Dose Escalation Open-Label Safety, Pharmacokinetic and Pharmacodynamic Study to Determine the Recommended Phase II Dose of GSK1120212 Dosed in Combination with GSK2141795

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.